Leef Brands, Inc.

LEEEF ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024
Revenue $34.8M $28.5M
Cost of Revenue $24.3M $20.8M
Gross Profit $10.5M $7.7M
Gross Margin 30.1% 27.0%
Operating Expenses
Research & Development $19.7K $19.0K
SG&A Expense $3.1M $2.4M
Operating Income $-7.6M $-8.0M
Operating Margin -21.8% -28.0%
Interest Expense $89.1K $80.1K
Pretax Income $-15.1M $-21.3M
Income Tax Expense $2.5M $3.3M
Net Income $-17.6M $-24.6M
Net Margin -50.7% -86.4%
EPS (Basic) $-0.10 $-0.17
EPS (Diluted) $-0.10 $-0.17
Shares Outstanding (Basic) 266.2M 184.9M 142.6M
Shares Outstanding (Diluted) 266.2M 184.9M 142.6M
Dividends Per Share